Company Shanghai Kehua Bio-Engineering Co.,Ltd

Equities

002022

CNE000001KC9

Medical Equipment, Supplies & Distribution

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sales per region

Annual profits - Rate of surprise

Sector Diagnostic & Testing Substances

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-04-17 pm EDT			5-day change	1st Jan Change
6.86 ^CNY	-0.58%		-9.26%	-39.72%

Apr. 15	Kehua Bio-Engineering Gets Registration Certificates for Two Devices	MT
Apr. 02	Tranche Update on Shanghai Kehua Bio-Engineering Co.,Ltd's Equity Buyback Plan announced on October 29, 2023.	CI

Shanghai Kehua Bio-engineering Co., Ltd. specializes in the development, manufacturing and marketing of diagnostic biological products. The group proposes primarily reagents, in vitro diagnostics agents, automated instruments of detection, etc.

China accounts for 91% of net sales.

Number of employees: 2,151

CNY in Million	2022	Weight	2023	Weight	Delta
Goods Production 58.4 %	5,390	77.3 %	1,417	58.4 %	-73.71%
Agent Product 39.6 %	1,490	21.4 %	962	39.6 %	-35.45%
Other Business 2.0 %	90	1.3 %	49	2.0 %	-45.06%

CNY in Million	2022	Weight	2023	Weight	Delta
China 85.3 %	6,306	90.5 %	2,071	85.3 %	-67.16%
Abroad 14.7 %	663	9.5 %	357	14.7 %	-46.18%

Managers	Title	Age	Since
Ming Li PSD	President	48	23-04-02
Fang Luo DFI	Director of Finance/CFO	52	21-03-31
Dun Fang Chen BRD	Director/Board Member	50	08-12-31
Hong Ying Jin BRD	Director/Board Member	52	22-10-16
Jun Tang IRC	Investor Relations Contact	43	-

Members of the board	Title	Age	Since
Hong Ying Jin BRD	Director/Board Member	52	22-10-16
Zhi Chao Ma CHM	Chairman	44	22-09-20
Ming Li PSD	President	48	23-04-02
Lan Xie CHM	Chairman	55	22-06-29
Hong Xu BRD	Director/Board Member	45	23-06-27
Chuan Fang Zheng BRD	Director/Board Member	58	23-06-27
Chao Yi BRD	Director/Board Member	41	23-06-27
Dun Fang Chen BRD	Director/Board Member	50	08-12-31

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	514,317,177	392,980,725 ( 76.41 %)	0	76.41 %

Name	Equities	%	Valuation
GREE REAL ESTATE CO.,LTD 18.65 %	95,863,038	18.65 %	106 M ¥
Bay Area Industry & Finance Investment Guangzhou Co. Ltd. 1.513 %	7,780,917	1.513 %	9 M ¥
Shanghai CR Asset Management Co., Ltd. 1.334 %	6,856,905	1.334 %	8 M ¥
Jiang Ming Dai 0.8315 %	4,274,900	0.8315 %	5 M ¥
Shanghai Jiaken Asset Management Co. Ltd. 0.7984 %	4,105,000	0.7984 %	5 M ¥
Teng Guang Lin 0.7906 %	4,064,925	0.7906 %	4 M ¥
Shaoguan Rongyu Enterprise Management Co. Ltd. 0.7494 %	3,852,959	0.7494 %	4 M ¥
Wei Qi Li 0.6341 %	3,260,000	0.6341 %	4 M ¥
Hong Wei Hu 0.6029 %	3,100,000	0.6029 %	3 M ¥
China Asset Management Co., Ltd. 0.4354 %	2,238,600	0.4354 %	2 M ¥

Shanghai Kehua Bio-Engineering Co., Ltd.

1189 North Qinzhou Road Xuhui District

200233, Shanghai

+86 21 6485 0088

http://www.skhb.com

address Shanghai Kehua Bio-Engineering Co.,Ltd(002022)

Company calendar

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Medical Equipment, Supplies & Distribution

Diagnostic & Testing Substances

	1st Jan change	Capi.
SHANGHAI KEHUA BIO-ENGINEERING CO.,LTD	-39.72%	490M
BIOMÉRIEUX	-1.59%	12.58B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-17.62%	6.82B
DIASORIN S.P.A.	-3.93%	5.14B
AUTOBIO DIAGNOSTICS CO., LTD.	-6.68%	4.22B
LANTHEUS HOLDINGS, INC.	+0.53%	4.21B
10X GENOMICS, INC.	-48.27%	3.47B
ANDON HEALTH CO., LTD.	+7.09%	2.65B
VITROLIFE AB	-13.71%	2.25B
MYRIAD GENETICS, INC.	-3.40%	1.69B

Diagnostic & Testing Substances